Clinical trial
Role of Intravenous Magnesium Sulphate in Improving Clinical Outcome in Patients Suffering From Acute Ischemic Stroke
NCT04412850 is registered in ClinicalTrials.gov with Dow University of Health Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Role of Intravenous Magnesium Sulphate in Improving Clinical Outcome in Patients Suffering From Acute Ischemic Stroke
- Lead sponsor
- Dow University of Health Sciences
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- December 1, 2020
- Completion date
- August 1, 2021
- Enrollment
- 44 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.